08/07/2025
6:30 AM | Telomir Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/18/2025
8:15 AM | Telomir Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/11/2025
8:30 AM | Telomir Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/10/2025
6:12 AM | Telomir Pharmaceuticals (Issuer)
Weichselbaum Alan (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/05/2025
7:00 AM | Telomir Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/02/2025
7:00 AM | Telomir Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/30/2025
7:00 PM | Aminov Erez (Reporting)
Telomir Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2025
7:00 AM | Telomir Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/21/2025
4:25 PM | Telomir Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/21/2025
7:45 AM | Telomir Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2025
6:45 AM | Telomir Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for TELO and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Telomir Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
05/07/2025
6:30 AM | Telomir Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/19/2025
6:30 AM | Telomir Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/02/2025
11:15 PM | Telomir Pharmaceuticals (Filer)
| Form EFFECT | |
02/18/2025
6:30 AM | Telomir Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/04/2025
3:05 PM | Aminov Erez (Reporting)
Telomir Pharmaceuticals (Issuer)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
01/28/2025
6:30 AM | Telomir Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/07/2025
6:30 AM | Telomir Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/23/2024
6:00 AM | Telomir Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/20/2024
4:00 PM | Telomir Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/02/2024
3:01 PM | Telomir Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/25/2024
4:06 PM | Bay Shore Trust (Reporting)
Telomir Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2024
3:15 PM | Telomir Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/27/2024
3:15 PM | Telomir Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/04/2024
12:37 PM | Telomir Pharmaceuticals (Issuer)
Yanez Michelle (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
3:37 PM | Telomir Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/29/2024
3:05 PM | Telomir Pharmaceuticals (Issuer)
Yanez Michelle (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/29/2024
3:05 PM | Telomir Pharmaceuticals (Issuer)
Whalen Matthew Pratt (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2024
3:05 PM | Del Giudice Matthew Paul (Reporting)
Telomir Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2024
3:05 PM | Aminov Erez (Reporting)
Telomir Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2024
3:05 PM | MacPherson Edward Clouston (Reporting)
Telomir Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2024
3:05 PM | Jerman Michael Allen (Reporting)
Telomir Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
MarketBeat All Access